Harvard Apparatus Regenerative Technology HRGN
OTC HRGN
$1.98 +0.17 (+9.39%)
At close: Nov 12, 2026 · 4:00 PM EST

Harvard Apparatus Regenerative Technology (HRGN) Sale and Maturity of Investments (2023)

Updated

Analysis

Harvard Apparatus Regenerative Technology (HRGN) Sale and Maturity of Investments (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 308.00 Mn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn -
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 405.00 Mn
5 Novartis Ag 306.35 Bn 279.93 Bn - 88.00 Mn
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn -
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 2.53 Bn
10 Harvard Apparatus Regenerative Technology 2.32 Mn -1.70 Mn 12,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 1.23 Mn
API Access

Harvard Apparatus Regenerative Technology Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=HRGN&period=max&api_key=YOUR_API_KEY